MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,485 | +20.6% | 80 | 0.0% | 0.00% | – |
| Q2 2023 | $2,890 | -2.8% | 80 | 0.0% | 0.00% | – |
| Q1 2023 | $2,974 | -18.0% | 80 | 0.0% | 0.00% | – |
| Q4 2022 | $3,625 | -39.6% | 80 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 80 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 80 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -41.7% | 80 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -20.0% | 80 | -3.6% | 0.00% | – |
| Q3 2021 | $15,000 | +114.3% | 83 | -79.2% | 0.00% | – |
| Q4 2014 | $7,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |